Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas.

Autor: Riviere-Cazaux C; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Lacey JM; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Carlstrom LP; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Laxen WJ; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Munoz-Casabella A; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Hoplin MD; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Ikram S; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Zubair AB; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Andersen KM; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Warrington AE; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Decker PA; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Kaufmann TJ; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Campian JL; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Eckel-Passow JE; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Kizilbash SH; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Tortorelli S; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Burns TC; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Jazyk: angličtina
Zdroj: Neuro-oncology advances [Neurooncol Adv] 2023 May 11; Vol. 5 (1), pp. vdad061. Date of Electronic Publication: 2023 May 11 (Print Publication: 2023).
DOI: 10.1093/noajnl/vdad061
Abstrakt: Competing Interests: None.
Databáze: MEDLINE